Novus Biologicals™ Peptide bloquant d’anticorps TACI/TNFRSF13B/CVID

Name: Novus Biologicals™ Peptide bloquant d’anticorps TACI/TNFRSF13B/CVID
Brand: Novus Biologicals
SKU: 18277965
Price: 201.94 EUR
Availability: InStock

Réf. : BL-RE-104865Réf. fabricant : 18277965 0.05 mg

201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez): 23495
Espèces: Human
Contenu et stockage: Store at -20 C. Avoid freeze-thaw cycles.
Formule: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application): This Peptide is Useful as a Blocking Peptide for NBP1-76779. For Further Blocking Peptide Related Protocol, Click Here .
Marque: Novus Biologicals

Caractéristiques techniques

Marque	Novus Biologicals
Réf. B-LABO	BL-RE-104865
Réf. fabricant	18277965
Gene ID (Entrez)	23495
Espèces	Human
Contenu et stockage	Store at -20 C. Avoid freeze-thaw cycles.
Formule	PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)	This Peptide is Useful as a Blocking Peptide for NBP1-76779. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gène	CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13 B, tumor necrosis factor receptor superfamily member 13 B, tumor necrosis factor receptor superfamily, member 13 B
Symbole de gène(s)	TNFRSF13B
Type de produit	TACI/TNFRSF13B/CVID
Quantité	0.05 mg
État réglementaire	RUO - research use only
Source	Synthetic
Consigne	15 amino amino terminus of human TACI